Methodological considerations for gene expression profiling of human brain

Gene expression profiles of postmortem brain tissue represent important resources for understanding neuropsychiatric illnesses. The impact(s) of quality covariables on the analysis and results of gene expression studies are important questions. This paper addressed critical variables which might affect gene expression in two brain regions. Four broad groups of quality indicators in gene expression profiling studies (clinical, tissue, RNA, and microarray quality) were identified. These quality control indicators were significantly correlated, however one quality variable did not account for the total variance in microarray gene expression. The data showed that agonal factors and low pH correlated with decreased integrity of extracted RNA in two brain regions. These three parameters also modulated the significance of alterations in mitochondrial-related genes. The average F-ratio summaries across all transcripts showed that RNA degradation from the AffyRNAdeg program accounted for higher variation than all other quality factors. Taken together, these findings confirmed prior studies, which indicated that quality parameters including RNA integrity, agonal factors, and pH are related to differences in gene expression profiles in postmortem brain. Individual candidate genes can be evaluated with these quality parameters in post hoc analysis to help strengthen the relevance to psychiatric disorders. We find that clinical, tissue, RNA, and microarray quality are all useful variables for collection and consideration in study design, analysis, and interpretation of gene expression results in human postmortem studies.

[1]  B. Winblad,et al.  The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue , 2005, Journal of Neural Transmission.

[2]  Paul J. Harrison,et al.  Pre‐and Postmortem Influences on Brain RNA , 1993, Journal of neurochemistry.

[3]  Huda Akil,et al.  Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain , 2004, Biological Psychiatry.

[4]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[5]  J. Wilusz,et al.  Bringing the role of mRNA decay in the control of gene expression into focus. , 2004, Trends in genetics : TIG.

[6]  A. Laptook,et al.  Effect of Hypoxia on Glucose-Modulated Cerebral Lactic Acidosis, Agonal Glycolytic Rates, and Energy Utilization , 1996, Pediatric Research.

[7]  R. Ross,et al.  Brain pH has a significant impact on human postmortem hippocampal gene expression profiles , 2006, Brain Research.

[8]  V. Arango,et al.  Molecular aging in human prefrontal cortex is selective and continuous throughout adult life , 2005, Biological Psychiatry.

[9]  GABA in Huntington's chorea, Parkinsonism and schizophrenia. , 1979 .

[10]  Thomas Ragg,et al.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.

[11]  R. Yolken,et al.  Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. , 2004, BioTechniques.

[12]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[13]  S. Peltz,et al.  The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro , 1989, Molecular and cellular biology.

[14]  P. Levitt,et al.  Critical Appraisal of DNA Microarrays in Psychiatric Genomics , 2006, Biological Psychiatry.

[15]  L. Iversen,et al.  Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects , 1980, Journal of the Neurological Sciences.

[16]  Charles Auffray,et al.  Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces , 2005, Nucleic acids research.

[17]  J. Kleinman,et al.  Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia , 2006, Biological Psychiatry.

[18]  J. Kleinman,et al.  Reliability of psychiatric diagnosis in postmortem research , 2005, Biological Psychiatry.

[19]  S. Pardue,et al.  Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat Brain , 1994, Cellular and Molecular Neurobiology.

[20]  H. Patel,et al.  Tissue microarrays: a current medical research tool , 2004, Current medical research and opinion.

[21]  F. Middleton,et al.  Altered Expression of 14-3-3 Genes in the Prefrontal Cortex of Subjects with Schizophrenia , 2005, Neuropsychopharmacology.

[22]  John F. Robinson,et al.  Quality assessment of microarray experiments. , 2005, Clinical biochemistry.

[23]  Karl Kornacker,et al.  Chipping away at the chip bias: RNA degradation in microarray analysis , 2003, Nature Genetics.

[24]  Eric S. Lander,et al.  Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Magnasco,et al.  Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. , 2003, Genome research.

[26]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.

[27]  Huda Akil,et al.  Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. , 2004, Human molecular genetics.

[28]  L. Iversen,et al.  INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSES , 1977, The Lancet.

[29]  E. Isometsä,et al.  Psychological autopsy studies – a review , 2001, European Psychiatry.

[30]  P. Levitt,et al.  DNA microarray analysis of postmortem brain tissue. , 2004, International review of neurobiology.

[31]  Hans-Georg Rammensee,et al.  Moderate degradation does not preclude microarray analysis of small amounts of RNA. , 2003, BioTechniques.

[32]  L. Iversen,et al.  DIFFERENTIAL EFFECTS OF AGONAL STATUS ON MEASUREMENTS OF GABA AND GLUTAMATE DECARBOXYLASE IN HUMAN POST‐MORTEM BRAIN TISSUE FROM CONTROL AND HUNTINGTON'S CHOREA SUBJECTS , 1979, Journal of neurochemistry.

[33]  C. Yates,et al.  Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other Dementias , 1990, Journal of neurochemistry.

[34]  Andrew L. Lemire,et al.  Deficient Hippocampal Neuron Expression of Proteasome, Ubiquitin, and Mitochondrial Genes in Multiple Schizophrenia Cohorts , 2005, Biological Psychiatry.

[35]  Andrew L. Lemire,et al.  Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures , 2004, Journal of Neuroscience Methods.

[36]  Paul J. Harrison,et al.  Terminal coma affects messenger RNA detection in post mortem human temporal cortex. , 1991, Brain research. Molecular brain research.

[37]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[38]  Kazuya Iwamoto,et al.  Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.

[39]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[41]  I. Ferrer,et al.  DNA Chip Technology in Brain Banks: Confronting a Degrading World , 2004, Journal of neuropathology and experimental neurology.

[42]  Sabine Bahn,et al.  Application and optimization of microarray technologies for human postmortem brain studies , 2004, Biological Psychiatry.

[43]  J. Wilusz,et al.  The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system , 1997, Molecular and cellular biology.

[44]  R. Myers,et al.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders , 2006, Molecular Psychiatry.

[45]  Samuel S Newton,et al.  Production of custom microarrays for neuroscience research. , 2005, Methods.

[46]  C D Marsden,et al.  Tissue pH as an indicator of mRNA preservation in human post-mortem brain. , 1995, Brain research. Molecular brain research.

[47]  C. Hulette,et al.  Recovery and Expression of Messenger RNA from Postmortem Human Brain Tissue , 2001, Modern Pathology.

[48]  Paul J. Harrison,et al.  The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins , 1995, Neuroscience Letters.

[49]  R. Yolken,et al.  Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR , 1997, Journal of Neuroscience Methods.

[50]  M. Webster,et al.  Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains , 2005, Biological Psychiatry.

[51]  G. Hardiman,et al.  Microarrays ‐ The Challenge of Preparing Brain Tissue Samples , 2005, Addiction biology.

[52]  P. Dodd,et al.  Biochemical and molecular studies using human autopsy brain tissue , 2003, Journal of neurochemistry.

[53]  Ben Bolstad,et al.  Low-level Analysis of High-density Oligonucleotide Array Data: Background, Normalization and Summarization , 2003 .

[54]  D. G. Standaert,et al.  Gene expression profiling in the post-mortem human brain — no cause for dismay , 2001, Journal of Chemical Neuroanatomy.

[55]  T. Crow,et al.  Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. , 1986, Experimental and molecular pathology.

[56]  S. Pardue,et al.  Heat‐Shock 70 Messenger RNA Levels in Human Brain: Correlation with Agonal Fever , 1995, Journal of neurochemistry.

[57]  J. Miller,et al.  Effect of pre- and postmortem variables on specific mRNA levels in human brain. , 1991, Brain research. Molecular brain research.

[58]  A. C. Collins,et al.  Effect of Smoking History on [ 3 H]nicotine Binding in Human Postmortem Brain 1 , 2022 .

[59]  Stephan Heckers,et al.  Molecular evidence for mitochondrial dysfunction in bipolar disorder. , 2004, Archives of general psychiatry.

[60]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[61]  Robert C. Thompson,et al.  Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis * , 2002, The European journal of neuroscience.

[62]  C. Finch,et al.  Extensive postmortem stability of RNA from rat and human brain , 1986, Journal of neuroscience research.

[63]  A. Thomson,et al.  mRNA Stability and the Control of Gene Expression: Implications for Human Disease , 2002, Neurochemical Research.

[64]  B. Shastry.  Bipolar disorder: an update , 2005, Neurochemistry International.

[65]  Huda Akil,et al.  Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. , 2003, The American journal of psychiatry.

[66]  Daniel H. Geschwind,et al.  Microarray Applications in Neuroscience , 2001, Neurobiology of Disease.

[67]  W. Wood,et al.  Assembly and use of a broadly applicable neural cDNA microarray. , 2001, Restorative neurology and neuroscience.

[68]  J. Wilusz,et al.  Messenger RNA decay in mammalian cells , 2007, Cell Biochemistry and Biophysics.

[69]  Jonathan Pevsner,et al.  Progress in the use of microarray technology to study the neurobiology of disease , 2004, Nature Neuroscience.

[70]  Kellie J Archer,et al.  Evaluation of quality-control criteria for microarray gene expression analysis. , 2004, Clinical chemistry.

[71]  M. Gerstein,et al.  Comparing protein abundance and mRNA expression levels on a genomic scale , 2003, Genome Biology.

[72]  T. Bottiglieri,et al.  MULTIPLE SCLEROSIS AND MACROCYTOSIS , 1989, The Lancet.

[73]  T. Kelly,et al.  Validity of DSM‐III‐R diagnosis by psychological autopsy: a comparison with clinician ante‐mortem diagnosis , 1996, Acta psychiatrica Scandinavica.

[74]  Albert Zlotnik,et al.  Effects of RNA degradation on gene expression analysis of human postmortem tissues , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  D. Brent,et al.  The validity of diagnoses obtained through the psychological autopsy procedure in adolescent suicide victims: use of family history , 1993, Acta psychiatrica Scandinavica.

[76]  G. Nickenig,et al.  The role of the AUUUUA hexamer for the posttranscriptional regulation of the AT1 receptor mRNA stability. , 2005, Biochemical and biophysical research communications.

[77]  N. Craddock,et al.  Genetics of bipolar disorder. , 2010, Journal of medical genetics.

[78]  Jennifer M. Taylor,et al.  A microarray study of post-mortem mRNA degradation in mouse brain tissue. , 2005, Brain research. Molecular brain research.

[79]  M. Mimmack,et al.  Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies , 2004, Biological Psychiatry.

[80]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[81]  A qualitative assessment of direct-labeled cDNA products prior to microarray analysis , 2005, BMC Genomics.

[82]  N. Cairns,et al.  Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. , 2003, Brain research. Molecular brain research.